These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 15302785

  • 1. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure.
    Bahlmann FH, Song R, Boehm SM, Mengel M, von Wasielewski R, Lindschau C, Kirsch T, de Groot K, Laudeley R, Niemczyk E, Güler F, Menne J, Haller H, Fliser D.
    Circulation; 2004 Aug 24; 110(8):1006-12. PubMed ID: 15302785
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.
    Logar CM, Brinkkoetter PT, Krofft RD, Pippin JW, Shankland SJ.
    Kidney Int; 2007 Aug 24; 72(4):489-98. PubMed ID: 17554257
    [Abstract] [Full Text] [Related]

  • 4. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
    Salahudeen AK, Haider N, Jenkins J, Joshi M, Patel H, Huang H, Yang M, Zhe H.
    Am J Physiol Renal Physiol; 2008 Jun 24; 294(6):F1354-65. PubMed ID: 18385271
    [Abstract] [Full Text] [Related]

  • 5. Erythropoietin attenuated high glucose-induced apoptosis in cultured human aortic endothelial cells.
    Sekiguchi N, Inoguchi T, Kobayashi K, Sonoda N, Nawata H.
    Biochem Biophys Res Commun; 2005 Aug 19; 334(1):218-22. PubMed ID: 15993382
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human erythropoietin ameliorated endothelial dysfunction and macrophage infiltration by increasing nitric oxide in hypertensive 5/6 nephrectomized rat aorta.
    Toba H, Morishita M, Tojo C, Nakano A, Oshima Y, Kojima Y, Yoshida M, Nakashima K, Wang J, Kobara M, Nakata T.
    Eur J Pharmacol; 2011 Apr 10; 656(1-3):81-7. PubMed ID: 21296066
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit.
    Lipsic E, Westenbrink BD, van der Meer P, van der Harst P, Voors AA, van Veldhuisen DJ, Schoemaker RG, van Gilst WH.
    Eur J Heart Fail; 2008 Jan 10; 10(1):22-9. PubMed ID: 18077209
    [Abstract] [Full Text] [Related]

  • 9. Erythropoietin prevents diabetes-induced podocyte damage.
    Schiffer M, Park JK, Tossidou I, Bartels J, Shushakova N, Menne J, Fliser D.
    Kidney Blood Press Res; 2008 Jan 10; 31(6):411-5. PubMed ID: 19096223
    [Abstract] [Full Text] [Related]

  • 10. Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat.
    Toba H, Sawai N, Morishita M, Murata S, Yoshida M, Nakashima K, Morita Y, Kobara M, Nakata T.
    Eur J Pharmacol; 2009 Jun 10; 612(1-3):106-14. PubMed ID: 19356735
    [Abstract] [Full Text] [Related]

  • 11. Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats.
    Cassis P, Azzollini N, Solini S, Mister M, Aiello S, Cugini D, Scudeletti P, Gagliardini E, Abbate M, Gallon L, Remuzzi G, Noris M.
    Transplantation; 2011 Aug 15; 92(3):271-9. PubMed ID: 21705971
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Darbepoetin enhances endothelium-dependent vasomotor function in patients with stable coronary artery disease only after preceding ischaemia/reperfusion.
    Tilling L, Hunt J, Donald A, Clapp B, Chowienczyk P.
    Clin Sci (Lond); 2012 Apr 15; 122(7):329-36. PubMed ID: 21966999
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.
    Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D, Harwood S, Raftery M, Thiemermann C, Yaqoob MM.
    J Am Soc Nephrol; 2004 Aug 15; 15(8):2115-24. PubMed ID: 15284297
    [Abstract] [Full Text] [Related]

  • 18. Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model.
    Kelly DJ, Zhang Y, Gow R, Gilbert RE.
    J Am Soc Nephrol; 2004 Oct 15; 15(10):2619-29. PubMed ID: 15466266
    [Abstract] [Full Text] [Related]

  • 19. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure.
    Johnson DW, Pat B, Vesey DA, Guan Z, Endre Z, Gobe GC.
    Kidney Int; 2006 May 15; 69(10):1806-13. PubMed ID: 16598197
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.